Personalized genomic medicine: Lessons from the exome

Benjamin D. Solomon, Daniel E. Pineda-Alvarez, Donald W. Hadley, Jamie K. Teer, Praveen F. Cherukuri, Nancy F. Hansen, Pedro Cruz, Alice C. Young, Robert W. Blakesley, Brendan Lanpher, Stephanie Mayfield Gibson, Murat Sincan, Settara C. Chandrasekharappa, James C. Mullikin

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


While genomic sequencing methods are powerful tools in the discovery of the genetic underpinnings of human disease, incidentally-revealed novel genomic risk factors may be equally important, both scientifically, and as relates to direct patient care. We performed whole-exome sequencing on a child with VACTERL association who suffered severe post-surgical neonatal pulmonary hypertension, and identified a potential novel genetic risk factor for this complication: a heterozygous mutation in CPSI. Newborn screening results from this patient's monozygotic twin provided evidence that this mutation, in combination with an environmental trigger (in this case, surgery), may have resulted in pulmonary artery hypertension due to inadequate nitric oxide production. Identification of this genetic risk factor allows for targeted medical preventative measures in this patient as well as relatives with the same mutation, and illustrates the power of incidental medical information unearthed by whole-exome sequencing.

Original languageEnglish (US)
Pages (from-to)189-191
Number of pages3
JournalMolecular genetics and metabolism
Issue number1-2
StatePublished - Sep 1 2011


  • CPSI
  • Pulmonary artery hypertension
  • Whole-exome sequencing

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology


Dive into the research topics of 'Personalized genomic medicine: Lessons from the exome'. Together they form a unique fingerprint.

Cite this